Logo 25 mg
Pill imprint Logo 25 mg has been identified as Cyclosporine 25 mg.
Cyclosporine is used in the treatment of psoriasis; organ transplant, rejection prophylaxis; organ transplant, rejection reversal; ulcerative colitis; rheumatoid arthritis (and more), and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy.
Cyclosporine 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Cyclosporine Images
- Imprint:
-
Logo 25 mg
- Strength:
- 25 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- alpha-tocopherol
FD&C Blue No. 2
aluminum oxide
gelatin
glycine
sorbitol
titanium dioxide
ferric oxide yellow
- Drug Class:
- Calcineurin inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-7310
Advertisement
More CycloSPORINE resources
- Cyclosporine (Wolters Kluwer)
- Cyclosporine Capsules (Wolters Kluwer)
- Cyclosporine Soft Gelatin Capsules (Wolters Kluwer)
- Cyclosporine Solution (Wolters Kluwer)
- cyclosporine (Cerner Multum)
- Apo-Cyclosporine (Micromedex) - Includes Dosage Information
- cyclosporine Oral, Intravenous (Micromedex) - Includes Dosage Information
- Cyclosporine (AHFS DI)
- Cyclosporine (FDA)
- Cyclosporine Capsules (FDA)
- Cyclosporine Injection (FDA)
- Cyclosporine (Cyclosporin A) (Wolters Kluwer)
CycloSPORINE is associated with the treatment of:
- Cogan's Syndrome
- Crohn's Disease
- Evan's Syndrome
- Focal Segmental Glomerulosclerosis
- Graft-versus-host disease
- Idiopathic Thrombocytopenic Purpura
- Inflammatory Bowel Disease
- Nephrotic Syndrome
- Organ Transplant, Rejection Prophylaxis
- Organ Transplant, Rejection Reversal
- Pemphigoid
- Pemphigus
- Psoriasis
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Ulcerative Colitis
- Ulcerative Colitis, Active
Search Again
